Literature DB >> 16246042

Adipose tissue function in the insulin-resistance syndrome.

F Karpe1, G D Tan.   

Abstract

Insulin resistance is often seen as a consequence of obesity and there are several possible links between adipose tissue function and insulin resistance determined in other organs such as skeletal muscle or liver. One such link is the regulation of NEFA (non-esterified fatty acid) delivery to the rest of the body. Simplistically, an expanded adipose tissue mass delivers more NEFA to the systemic circulation and these fatty acids compete for substrate utilization in skeletal muscle, which in turn reduces glucose utilization. This increases blood glucose concentration and provides the stimulus for increased insulin secretion and hyperinsulinaemia is a key feature of the insulin-resistance syndrome. However, there is abundant evidence that adipose tissue is exquisitely insulin sensitive and hyperinsulinaemia may therefore lead to a constant lipolytic inhibition in adipose tissue. Consequently, the main function of adipose tissue, to rapidly switch between fat uptake and fat release, will be hampered. Adipose tissue blood flow is the conveyor of signals and substrates to and from the adipose tissue. In healthy people adipose tissue blood flow is much enhanced by food intake, whereas in insulin-resistant subjects this response is blunted. This is another facet of unresponsiveness of adipose tissue in the insulin-resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246042     DOI: 10.1042/BST0331045

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Decreased expression of adipose CD36 and FATP1 are associated with increased plasma non-esterified fatty acids during prolonged fasting in northern elephant seal pups (Mirounga angustirostris).

Authors:  Jose Abraham Viscarra; José Pablo Vázquez-Medina; Ruben Rodriguez; Cory D Champagne; Sean H Adams; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2012-07-15       Impact factor: 3.312

2.  Effect of beta-adrenergic stimulation on whole-body and abdominal subcutaneous adipose tissue lipolysis in lean and obese men.

Authors:  J W E Jocken; G H Goossens; A M J van Hees; K N Frayn; M van Baak; J Stegen; M T W Pakbiers; W H M Saris; E E Blaak
Journal:  Diabetologia       Date:  2007-12-05       Impact factor: 10.122

3.  PTEN mutations as a cause of constitutive insulin sensitivity and obesity.

Authors:  Aparna Pal; Thomas M Barber; Martijn Van de Bunt; Simon A Rudge; Qifeng Zhang; Katherine L Lachlan; Nicola S Cooper; Helen Linden; Jonathan C Levy; Michael J O Wakelam; Lisa Walker; Fredrik Karpe; Anna L Gloyn
Journal:  N Engl J Med       Date:  2012-09-13       Impact factor: 91.245

4.  Adipose triglyceride lipase and hormone-sensitive lipase are involved in fat loss in JunB-deficient mice.

Authors:  Montserrat Pinent; Andreas Prokesch; Hubert Hackl; Peter J Voshol; Ariane Klatzer; Evelyn Walenta; Ute Panzenboeck; Lukas Kenner; Zlatko Trajanoski; Gerald Hoefler; Juliane G Bogner-Strauss
Journal:  Endocrinology       Date:  2011-05-03       Impact factor: 5.051

5.  Loss of regulator of G protein signaling 5 exacerbates obesity, hepatic steatosis, inflammation and insulin resistance.

Authors:  Wei Deng; Xinan Wang; Jinfeng Xiao; Kuoju Chen; Heng Zhou; Difei Shen; Hongliang Li; Qizhu Tang
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

6.  Mitochondria-targeted dodecyltriphenylphosphonium (C12TPP) combats high-fat-diet-induced obesity in mice.

Authors:  A V Kalinovich; C L Mattsson; M R Youssef; N Petrovic; M Ost; V P Skulachev; I G Shabalina
Journal:  Int J Obes (Lond)       Date:  2016-08-18       Impact factor: 5.095

7.  Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation.

Authors:  Paweł Burchardt; Jakub Zurawski; Bartosz Zuchowski; Tomasz Kubacki; Dawid Murawa; Krzysztof Wiktorowicz; Henryk Wysocki
Journal:  Arch Med Sci       Date:  2013-02-10       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.